Establishment Labs (ESTA)
(Delayed Data from NSDQ)
$44.52 USD
-1.67 (-3.62%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $44.49 -0.03 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Establishment Labs Holdings Inc. (ESTA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$59.14 | $75.00 | $45.00 | 28.04% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Establishment Labs Holdings Inc. comes to $59.14. The forecasts range from a low of $45.00 to a high of $75.00. The average price target represents an increase of 28.04% from the last closing price of $46.19.
Analyst Price Targets (7 )
Broker Rating
Establishment Labs Holdings Inc. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ESTA.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/22/2024 | Not Identified | Not Identified | Hold | Hold |
8/7/2024 | Stephens | George Sellers | Strong Buy | Strong Buy |
6/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
4/1/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $59.14 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 168 of 253 |
Current Quarter EPS Est: | -0.61 |